Sponsored Links 
Cytokinetics Enters Oversold Territory
Cytokinetics Inc.’s (CYTK - Snapshot Report) share price has moved into oversold territory with a stochastic value of 5.94. The Zacks Consensus Estimate on the company’s full-year earnings has climbed 40 cents over the past 3 months to 36 cents per share. Cytokinetics is a Zacks #1 Rank (“Strong Buy”) company.
 |
 |
 Share |
 RSS |
 Rate Pos |
 Rate Neg |
 Comment |
|
|
||||||
Loading Stories...Related Content
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
- Free Four Zacks #1 Rank "Strong Buy" Stocks
- Free Timely Market Commentary
- Free Wealth Management Tips
- Free Profitable Strategy Screens
- Free Bull and Bear Stocks of the Day
Zacks FREE Registration
X Close
Loading Stories...Most Popular on Zacks.com
-1.76 %
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
More Zacks Links
| Market Summary | Nov 25, 2009 14:49 pm ET |
31.90
Sponsored Links
[CLICK TO CLOSE X]